190
Views
8
CrossRef citations to date
0
Altmetric
Articles

Synthesis, X-ray analysis and computational studies of two novel thiophene derivatives

, , , , , , , & ORCID Icon show all
Pages 517-529 | Received 11 Oct 2019, Accepted 10 May 2020, Published online: 25 May 2020
 

ABSTRACT

Thiophene is a core structure in many marketed drugs, such as Duloxetine, Tiotropium, Raloxifene, Dorzolamide, Tioconazole, Citizolam, Sertaconazole Nitrate and Benocyclidine. Thiophene derivatives are reported to have several types of pharmacological and biological activities. The synthesis of new thiophene derivatives is important to pharmaceutical research, because of their diverse pharmacological activities. The reaction of ethyl 3-oxobutanoate with carbon disulfide and chloroacetone in the presence of K2CO3 affords the unexpected thiophene derivative 7. Furthermore, refluxing compound 7 with dimethylformamide-dimethylacetal (DMF-DMA) in DMF affords the enaminone derivative 8. The structures of these newly synthesized compounds were confirmed by means of various spectroscopic techniques, such as IR, MS, and NMR, as well as by X-ray diffraction. In addition, B3LYP/6-311G(d, p) basis sets were employed to optimize the molecular geometry of the two thiophene derivatives. Furthermore, natural atomic charges and frontier molecular orbital analyses were performed. Hirshfeld analysis of the molecular packing showed that H—H, O—H, C—H, and S—H are the most common intermolecular interactions in both compounds. Further analysis suggests that the O—H interactions are the most significant of these in compounds 7 and 8.

GRAPHICAL ABSTRACT

Acknowledgements

The authors extend their appreciation to the Deanship of Scientific Research at King Khalid University for funding this research (R.G.P. 2/83/41).

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The authors extend their appreciation to the Deanship of Scientific Research at King Khalid University for funding this research (R.G.P. 2/83/41).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.